HDFC Ltd all set to acquire majority stake in Apollo Munich Health Insurance for Rs 1,336 crore

HDFC Ltd will be acquiring the entire 50.8 per cent shareholding of Apollo Group in Apollo Munich Health Insurance Company for Rs 1,336 crore, according to an announcement here on Wednesday. Both HDFC and Apollo Hospitals Group approved entering into definitive agreements for HDFC to acquire the entire 50.8 per cent shareholding of Apollo Group. However, the proposed share acquisition will be subject to regulatory approvals by National Housing Bank (NHB), Insurance Regulatory and Development Authority of India (IRDAI) and Competition Commission of India (CCI). 

Here are the highlights of the deal:

1. The deal was for a consideration of Rs 1,336 crore and 0.4 per cent shareholding held by a few employees for a consideration of Rs 10.84 crore, subject to regulatory approvals, a statement said. 

2. Post-acquisition of the shares by HDFC, Apollo Munich shall be merged with its general insurance subsidiary, HDFC ERGO General Insurance Company Limited (HDFC ERGO), subject to all regulatory, shareholders and other approvals.

3. To support the transaction with its material benefits for Apollo Munich, Munich Health will pay Rs 294 crore to Apollo Hospitals Enterprise Ltd and Apollo Energy Ltd in connection with the termination of their joint venture.

4. The proposed transaction brings together two large insurance players with complementary capabilities. The merged insurance entity has a combined market share of 6.4 per cent of non-life insurance industry with 308 branches across the country.

5. This also makes the combined entity the second largest private insurer in the accident and health segment with a market share of 8.2 per cent. 

6. The proposed merger is expected to result in significant benefits to policy holders and other stake holders with an enhanced product suite, touch points, technology innovation, as also via scale based synergies, the statement added.

7. The subsequent merger of Apollo Munich with HDFC ERGO would be subject to approval of the shareholders, National Company Law Tribunal (NCLT), and the final approval of IRDAI.